The US Department of Health and Human Services is to cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like Covid-19 and the flu. Robert F ...

The Department of Health and Human Services plans to cancel contracts and pull funding for some vaccines being developed to ...

Nxera Pharma has launched a broad proprietary pipeline focused on next-generation therapies for obesity and related metabolic ...

US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has said he will cut $500 million in funding for mRNA ...

The US Department of Health and Human Services (HHS) has announced it will wind down its mRNA vaccine development efforts under the Biomedical Advanced Research and Development Authority (BARDA), ...

Key Points Non-GAAP EPS was ($0.13), missing the consensus estimate by $0.02 (non-GAAP), due to higher pre-commercialization spending. Research and development expenses fell 48.2% compared to Q2 2024, ...